NO20014192D0 - Method of increasing bone volume using non-naturally occurring EP-selective agonists - Google Patents

Method of increasing bone volume using non-naturally occurring EP-selective agonists

Info

Publication number: NO20014192D0
Authority: NO; Norway
Prior art keywords: naturally occurring; bone volume; increasing bone; selective agonists; agonists
Prior art date: 1999-03-05

Application number

NO20014192A

Other languages

Norwegian (no)

Other versions

NO20014192L (en

Inventor

James Richard Hartke

Mark Walden Lundy

Mitchell Anthony Delong

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-05

Filing date

2001-08-29

Publication date

2001-08-29

2001-08-29 Application filed by Procter & Gamble filed Critical Procter & Gamble

2001-08-29 Publication of NO20014192D0 publication Critical patent/NO20014192D0/en

2001-11-05 Publication of NO20014192L publication Critical patent/NO20014192L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20014192A 1999-03-05 2001-08-29 Method of increasing bone volume using non-naturally occurring EP1 selective agonists NO20014192L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12306399P	1999-03-05	1999-03-05
PCT/US2000/005196 WO2000051585A2 (en)	1999-03-05	2000-03-01	Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume

Publications (2)

Publication Number	Publication Date
NO20014192D0 true NO20014192D0 (en)	2001-08-29
NO20014192L NO20014192L (en)	2001-11-05

Family

ID=22406507

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014192A NO20014192L (en)	1999-03-05	2001-08-29	Method of increasing bone volume using non-naturally occurring EP1 selective agonists

Country Status (10)

Country	Link
EP (1)	EP1158969A2 (en)
JP (1)	JP2002538105A (en)
AU (1)	AU3711900A (en)
CA (1)	CA2366755A1 (en)
CO (1)	CO5150205A1 (en)
IL (1)	IL145128A0 (en)
NO (1)	NO20014192L (en)
NZ (1)	NZ513828A (en)
PE (1)	PE20001552A1 (en)
WO (1)	WO2000051585A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1878429B1 (en)	2005-04-28	2011-08-03	Ono Pharmaceutical Co., Ltd.	Trenadermal absorption preparation
WO2008050848A1 (en)	2006-10-26	2008-05-02	Ono Pharmaceutical Co., Ltd.	Adhesive preparation
JPWO2009133863A1 (en)	2008-04-28	2011-09-01	国立大学法人浜松医科大学	Immunopotentiator comprising EP1 agonist
WO2011109729A2 (en) *	2010-03-05	2011-09-09	University Of Rochester	Ep1 inhibition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3982016A (en) *	1975-08-06	1976-09-21	Pfizer Inc.	Bone deposition by 16-aryl-13,14-dihydro-PGE2 p-biphenyl esters
US4621100A (en) *	1981-09-25	1986-11-04	The Upjohn Company	Treatment of osteoporosis with prostaglandins
US4812304A (en) *	1984-12-21	1989-03-14	The Procter & Gamble Company	Treatment of osteoporosis
WO1992021350A1 (en) *	1991-05-29	1992-12-10	Sepracor, Inc.	Combination of nsaids and prostaglandins and uses therefor
KR20010023840A (en) *	1997-09-09	2001-03-26	데이비드 엠 모이어	Method of increasing bone volume using non-naturally-occurring fp selective agonists
CA2346031A1 (en) *	1998-10-15	2000-04-20	Merck & Co., Inc.	Methods for stimulating bone formation
WO2000051616A1 (en) *	1999-03-05	2000-09-08	The Procter & Gamble Company	Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives

2000
- 2000-03-01 AU AU37119/00A patent/AU3711900A/en not_active Abandoned
- 2000-03-01 IL IL14512800A patent/IL145128A0/en unknown
- 2000-03-01 JP JP2000602053A patent/JP2002538105A/en not_active Withdrawn
- 2000-03-01 EP EP00915937A patent/EP1158969A2/en not_active Withdrawn
- 2000-03-01 CA CA002366755A patent/CA2366755A1/en not_active Abandoned
- 2000-03-01 NZ NZ513828A patent/NZ513828A/en not_active Application Discontinuation
- 2000-03-01 WO PCT/US2000/005196 patent/WO2000051585A2/en not_active Application Discontinuation
- 2000-03-03 PE PE2000000184A patent/PE20001552A1/en not_active Application Discontinuation
- 2000-03-06 CO CO00016009A patent/CO5150205A1/en unknown
2001
- 2001-08-29 NO NO20014192A patent/NO20014192L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
PE20001552A1 (en)	2001-01-30
CO5150205A1 (en)	2002-04-29
AU3711900A (en)	2000-09-21
EP1158969A2 (en)	2001-12-05
WO2000051585A3 (en)	2001-01-25
WO2000051585A2 (en)	2000-09-08
NO20014192L (en)	2001-11-05
IL145128A0 (en)	2002-06-30
JP2002538105A (en)	2002-11-12
NZ513828A (en)	2001-09-28
CA2366755A1 (en)	2000-09-08

Publication	Publication Date	Title
NO20001171D0 (en)	2000-03-07	Procedure for increasing bone volume using non-naturally occurring FP-selective agonists
AU2855700A (en)	2000-08-07	Methods and apparatus for brokering transactions
AU3872300A (en)	2000-09-28	Polypectomy snare instrument
AU2003239178A1 (en)	2003-11-10	Method for making tissue and towel products containing crosslinked cellulosic fibers
ZA200107291B (en)	2003-02-26	Use of xenon for treating neurointoxications.
SG127691A1 (en)	2006-12-29	Methods and instruments for improving refractive ophthalmic surgery
AU2001275860A1 (en)	2002-07-24	Surgical prep solution applicator system and methods
AU2001249967A1 (en)	2001-10-23	Composition and methods for tissue preservation
NO20001870L (en)	2000-10-16	New procedure for treatment
AU2001255602A1 (en)	2001-11-12	Methods for treating bone tumors
AU2002213114A1 (en)	2002-04-22	Compositions and methods for reducing gnrh-induced bone loss
NO20014429L (en)	2001-11-09	Electropolymerizable film, method of preparation and use thereof
NO20021823L (en)	2002-04-18	Treatment of emphysema using RAR-selective retinoid agonists
AU2001228703A1 (en)	2001-08-14	Use of cox-2 inhibitors for the treatment of constipation
NO20014192D0 (en)	2001-08-29	Method of increasing bone volume using non-naturally occurring EP-selective agonists
NO20014848D0 (en)	2001-10-05	Method of using Emamectin in the treatment of fish parasites
AU5179800A (en)	2000-12-28	Mycolactone and related compounds, compositions and methods of use
HK1047687A1 (en)	2003-03-07	Device for coagulation of tissues
AU2001255730A1 (en)	2001-11-07	Methods and compositions for the treatment of cardiac indications
NO20014193L (en)	2001-11-05	Method of increasing bone volume using non-naturally occurring FP-selective agonists and antiresorptive compounds
AU4206400A (en)	2000-11-02	Methods and apparatus for brokering transactions
AU2002256967A1 (en)	2002-09-12	Treating or reducing the risk of cardiovascular disease
AU4021700A (en)	2000-10-09	Methods of use of beta1-integrin inhibitors
AU2001244025A1 (en)	2001-10-23	Method for predicting the results of cosmetic surgery
AU2001229209A1 (en)	2002-05-21	Hydrokeratome for refractive surgery

Legal Events

Date	Code	Title	Description
2002-05-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application